SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-181310
Filing Date
2020-06-29
Accepted
2020-06-26 20:06:31
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d948820d424b5.htm 424B5 588833
2 GRAPHIC g948820g46w53.jpg GRAPHIC 47816
3 GRAPHIC g948820g74n27.jpg GRAPHIC 46421
  Complete submission text file 0001193125-20-181310.txt   715358
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-233061 | Film No.: 20995633
SIC: 2834 Pharmaceutical Preparations